PURPOSE: To assess the predisposing factors and clinical characteristics of pelvic insufficiency fractures (PIF) in postmenopausal women with pelvic irradiation. MATERIAL AND METHODS: A total 335 postmenopausal patients with cervical cancer of the intact uterus treated with radiation therapy between 1983 and 1998 were reviewed. Total external dose was delivered between 45 and 50.4 Gy with parallel opposed anteroposterior portals. Total brachytherapy dose at point A was delivered between 10 and 36 Gy. PIF were diagnosed by bone scintigraphy and confirmed by computed tomography. The cumulative incidence of symptomatic PIF was estimated by actuarial methods. Potential risk factors (age, weight, type II diabetes, delivery, menopause, total external dose, total brachytherapy dose) were assessed. RESULTS: Fifty-seven (17.0%) of 335 patients were diagnosed as having PIF. Forty-seven patients were symptomatic and ten were asymptomatic. Parameters carrying a significant association with PIF were body weight 49 kg or below (P=0.044) in stepwise logistic regression analysis. The cumulative incidence of symptomatic PIF at 5 years was 17.9% calculated by the Kaplan-Meier method. A body weight of 49 kg or below and more than three deliveries were identified as having a significant effect on symptomatic PIF in univariate analysis (P=0.021, P=0.003, log-rank test) and Cox life table regression analysis (P=0.038, P=0.013). Five patients required narcotic agents and eight patients required hospital admission. CONCLUSIONS: We should consider reducing the dose contribution to the sacrum and sacroilac joints, without underdosing the tumor, especially in postmenopausal women with many deliveries or low body weight.
PURPOSE: To assess the predisposing factors and clinical characteristics of pelvic insufficiency fractures (PIF) in postmenopausal women with pelvic irradiation. MATERIAL AND METHODS: A total 335 postmenopausal patients with cervical cancer of the intact uterus treated with radiation therapy between 1983 and 1998 were reviewed. Total external dose was delivered between 45 and 50.4 Gy with parallel opposed anteroposterior portals. Total brachytherapy dose at point A was delivered between 10 and 36 Gy. PIF were diagnosed by bone scintigraphy and confirmed by computed tomography. The cumulative incidence of symptomatic PIF was estimated by actuarial methods. Potential risk factors (age, weight, type II diabetes, delivery, menopause, total external dose, total brachytherapy dose) were assessed. RESULTS: Fifty-seven (17.0%) of 335 patients were diagnosed as having PIF. Forty-seven patients were symptomatic and ten were asymptomatic. Parameters carrying a significant association with PIF were body weight 49 kg or below (P=0.044) in stepwise logistic regression analysis. The cumulative incidence of symptomatic PIF at 5 years was 17.9% calculated by the Kaplan-Meier method. A body weight of 49 kg or below and more than three deliveries were identified as having a significant effect on symptomatic PIF in univariate analysis (P=0.021, P=0.003, log-rank test) and Cox life table regression analysis (P=0.038, P=0.013). Five patients required narcotic agents and eight patients required hospital admission. CONCLUSIONS: We should consider reducing the dose contribution to the sacrum and sacroilac joints, without underdosing the tumor, especially in postmenopausal women with many deliveries or low body weight.
Authors: V Nardone; P Tini; S F Carbone; A Grassi; M Biondi; L Sebaste; T Carfagno; E Vanzi; G De Otto; G Battaglia; G Rubino; P Pastina; G Belmonte; L N Mazzoni; F Banci Buonamici; M A Mazzei; L Pirtoli Journal: Osteoporos Int Date: 2017-02-27 Impact factor: 4.507
Authors: Olivier van Wulfften Palthe; Kyung-Wook Jee; Jos A M Bramer; Francis J Hornicek; Yen-Lin E Chen; Joseph H Schwab Journal: Clin Orthop Relat Res Date: 2018-03 Impact factor: 4.176
Authors: Louis Bazire; Haoping Xu; Jean-Philippe Foy; Malika Amessis; Caroline Malhaire; Kim Cao; Anne De La Rochefordiere; Youlia M Kirova Journal: Br J Radiol Date: 2017-03-14 Impact factor: 3.039
Authors: Michael P Herman; Scott Kopetz; Priya R Bhosale; Cathy Eng; John M Skibber; Miguel A Rodriguez-Bigas; Barry W Feig; George J Chang; Marc E Delclos; Sunil Krishnan; Christopher H Crane; Prajnan Das Journal: Int J Radiat Oncol Biol Phys Date: 2009-01-13 Impact factor: 7.038
Authors: Kathleen M Schmeler; Anuja Jhingran; Revathy B Iyer; Charlotte C Sun; Patricia J Eifel; Pamela T Soliman; Pedro T Ramirez; Michael Frumovitz; Diane C Bodurka; Anil K Sood Journal: Cancer Date: 2010-02-01 Impact factor: 6.860
Authors: Jeffrey S Willey; Shane A J Lloyd; Michael E Robbins; J Daniel Bourland; Hope Smith-Sielicki; Laura C Bowman; Robert W Norrdin; Ted A Bateman Journal: Radiat Res Date: 2008-09 Impact factor: 2.841
Authors: Jeffrey S Willey; Eric W Livingston; Michael E Robbins; J Daniel Bourland; Leidamarie Tirado-Lee; Hope Smith-Sielicki; Ted A Bateman Journal: Bone Date: 2009-09-09 Impact factor: 4.398